M
48
2
PNR
60
3
ABBV
48
2
EIX
62
3
HBI
56
3
ECL
57
3
LMT
44
5
GRMN
59
6
CMS
60
2
CAG
36
2
FMC
22
2
UNP
40
2
MHK
27
2
BF.B
35
2
HP
38
4
AEP
43
-4
WAT
59
4
SJM
21
2
TRIP
66
2
NUE
41
2
M
48
2
PNR
60
3
ABBV
48
2
EIX
62
3
HBI
56
3
ECL
57
3
LMT
44
5
GRMN
59
6
CMS
60
2
CAG
36
2
FMC
22
2
UNP
40
2
MHK
27
2
BF.B
35
2
HP
38
4
AEP
43
-4
WAT
59
4
SJM
21
2
TRIP
66
2
NUE
41
2
Financhill
Back

Essilorluxottica 10K Form

Buy
66

ESLOY
Essilorluxottica

Last Price:
$120.96
Seasonality Move:
0.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ESLOY News And Ratings

See the #1 stock for the next 7 days that we like better than ESLOY

ESLOY Financial Statistics

Sales & Book Value

Annual Sales: $27.5B
Cash Flow: $0
Price / Cash Flow: 30.8
Annual Sales: $45.91
Price / Book: 2.66

Profitability

EPS (TTM): 2.70820
Net Income (TTM): $2.5B
Gross Margin: $17.4B
Return on Equity: 5.83%
Return on Assets: 3.74%

Essilorluxottica Earnings Forecast

Key Essilorluxottica Financial Ratios

  • The Gross Profit Margin over the past 23 years for ESLOY is 63.19%.
  • The Selling, General & Administrative Expenses for ESLOY have been equal to 47.45% of Gross Profit Margin.
  • The Research & Development expenses have been 2.34% of Revenue.
  • The Interest Expense is 8.65% of Operating Income.
  • The Net Earning history of ESLOY is 9.01% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 17 years.

Essilorluxottica Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ESLOY
Website: essilorluxottica.com

Debt

Debt-to-Equity Ratio: 0.22
Current Ratio: 0.88
Quick Ratio: 0.53

Price-to-Earnings

Trailing P/E Ratio: 44.22
Forward P/E Ratio: 0

ESLOY Technical Analysis vs Fundamental Analysis

Buy
66
Essilorluxottica (ESLOY) is a Buy

Is Essilorluxottica a Buy or a Sell?

  • Essilorluxottica stock is rated a Buy
    The current Essilorluxottica [ESLOY] share price is $121.59. The Score for ESLOY is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.